Vimarsana
Biggest News Aggregation in the World

Microbot Medical News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Microbot Medical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Microbot Medical Today - Breaking & Trending Today

Microbot Medical Announces Closing of $2.35 Million - Vimarsana News

Microbot Medical Announces Closing of $2.35 Million

HINGHAM, Mass., June 04, 2024 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) today announced that it has closed its previously announced...

Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced ... - Vimarsana News

Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced ...

HINGHAM, Mass., June 04, 2024 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) today announced that it has closed its previously announced registered direct offering priced at-the-market under Nasdaq rules

Head-To-Head Review: Microbot Medical (NASDAQ:MBOT) & Vapotherm (NYSE:VAPO) - Vimarsana News

Head-To-Head Review: Microbot Medical (NASDAQ:MBOT) & Vapotherm (NYSE:VAPO)

Microbot Medical (NASDAQ:MBOT – Get Free Report) and Vapotherm (NYSE:VAPO – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, institutional ownership, earnings, profitability, risk and analyst recommendations. Analyst Ratings This is a breakdown of current […]

Can Fite BioPharma : NOTICE OF 2024 ANNUAL GENERAL MEETING OF SHAREHOLDERS - Form 6-K - Vimarsana News

Can Fite BioPharma : NOTICE OF 2024 ANNUAL GENERAL MEETING OF SHAREHOLDERS - Form 6-K

NOTICE OF 2024 ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON June 26, 2024 To the shareholders of Can-Fite BioPharma Ltd.: ...

Microbot Medical (NASDAQ:MBOT) Price Target Lowered to $7.00 at HC Wainwright - Vimarsana News

Microbot Medical (NASDAQ:MBOT) Price Target Lowered to $7.00 at HC Wainwright

Microbot Medical (NASDAQ:MBOT – Free Report) had its target price decreased by HC Wainwright from $8.00 to $7.00 in a report released on Tuesday morning, Benzinga reports. HC Wainwright currently has a buy rating on the biotechnology company’s stock. HC Wainwright also issued estimates for Microbot Medical’s Q1 2024 earnings at ($0.17) EPS, Q2 2024 […]

Source: wkrb13.com